Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 10, 2022

Total Value: $140M (100.0% shares, 0.0% debt)

Holdings (19)

BBIO BridgeBio Pharma Inc. (BBIO) 39.3%

Value $55.1M Shares 6,068,125 Est. Cost $40.43 Unrealized -79.3%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 14.1%

Value $19.72M Shares 1,025,000 Est. Cost $10.24 Unrealized +62.7%

GLUE Monte Rosa Therapeutics Inc. (GLUE) 10.2%

Value $14.24M Shares 1,472,331 Est. Cost $20.37 Unrealized -50.7%

BMEA Biomea Fusion Inc. (BMEA) 6.8%

Value $9.569M Shares 798,757 Est. Cost $17.65 Unrealized -66.8%

ACRS Aclaris Theraputics Inc. (ACRS) 6.3%

Value $8.857M Shares 634,455 Est. Cost $10.31 Unrealized +36.0%

NUVB Nuvation Bio Inc. (NUVB) 5.9%

Value $8.233M Shares 2,541,009 Est. Cost $11.18 Unrealized -61.0%

— Verona Pharma plc (VRNA) 4.0%

Value $5.583M Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Elevation Oncology Inc. (ELEV) 2.8%

Value $3.969M Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Talaris Therapeutics Inc. (TALS) 2.2%

Value $3.08M Shares 682,923 Est. Cost $14.69 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 1.9%

Value $2.692M Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Reneo Pharmaceuticals Inc. (RPHM) 1.7%

Value $2.348M Shares 886,075 Est. Cost $9.33 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 1.5%

Value $2.098M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.8%

Value $1.12M Shares 288,571 Est. Cost $11.34 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 0.7%

Value $1.037M Shares 3,142,857 Est. Cost $4.35 Unrealized —

— AVROBIO, Inc. (AVRO) 0.7%

Value $929K Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Aeglea Biotherapeutics Inc. (AGLE) 0.6%

Value $854K Shares 1,691,151 Est. Cost $8.00 Unrealized —

— Atreca Inc. (BCEL) 0.5%

Value $694K Shares 387,653 Est. Cost $18.84 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.0%

Value $24,000 Shares 77,663 Est. Cost $2.15 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.0%

Value $16,000 Shares 90,000 Est. Cost $1.66 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$55.1M	39.3%	$40.43	-79.3%	COM	10806X102
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$19.72M	14.1%	$10.24	+62.7%	COM	87164F105
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$14.24M	10.2%	$20.37	-50.7%	COM	61225M102
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$9.569M	6.8%	$17.65	-66.8%	COM	09077A106
ACRS	Aclaris Theraputics Inc. (ACRS)	634,455	$8.857M	6.3%	$10.31	+36.0%	COM	00461U105
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$8.233M	5.9%	$11.18	-61.0%	COM CL A	67080N101
—	Verona Pharma plc (VRNA)	1,332,485	$5.583M	4.0%	$7.38	—	SPONSORED ADS	925050106
—	Elevation Oncology Inc. (ELEV)	2,834,910	$3.969M	2.8%	$13.57	—	COM	28623U101
—	Talaris Therapeutics Inc. (TALS)	682,923	$3.08M	2.2%	$14.69	—	COM	87410C104
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$2.692M	1.9%	$8.87	—	COM	73730P108
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$2.348M	1.7%	$9.33	—	COM	75974E103
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$2.098M	1.5%	$24.31	—	COM	85209E109
—	Viracta Therapeutics Inc. (VIRX)	288,571	$1.12M	0.8%	$11.34	—	COM	92765F108
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$1.037M	0.7%	$4.35	—	COM	57055L107
—	AVROBIO, Inc. (AVRO)	1,009,779	$929K	0.7%	$16.72	—	COM	05455M100
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$854K	0.6%	$8.00	—	COM	00773J103
—	Atreca Inc. (BCEL)	387,653	$694K	0.5%	$18.84	—	CL A COM	04965G109
—	Zosano Pharma Corporation (ZSAN)	77,663	$24,000	0.0%	$2.15	—	COM NEW	98979H202
—	Nabriva Therapeutics plc (NBRV)	90,000	$16,000	0.0%	$1.66	—	SHS	G63637113